JP2009531047A - 細胞を処理または選択するための方法と装置 - Google Patents

細胞を処理または選択するための方法と装置 Download PDF

Info

Publication number
JP2009531047A
JP2009531047A JP2009502136A JP2009502136A JP2009531047A JP 2009531047 A JP2009531047 A JP 2009531047A JP 2009502136 A JP2009502136 A JP 2009502136A JP 2009502136 A JP2009502136 A JP 2009502136A JP 2009531047 A JP2009531047 A JP 2009531047A
Authority
JP
Japan
Prior art keywords
cells
cell
nemosis
sample
compartment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009502136A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009531047A5 (https=
Inventor
ビジク，ヨゼフ
ハルユラ，アリ
カンクリ，エスコ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2009531047A publication Critical patent/JP2009531047A/ja
Publication of JP2009531047A5 publication Critical patent/JP2009531047A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2009502136A 2006-03-31 2007-03-30 細胞を処理または選択するための方法と装置 Pending JP2009531047A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78766006P 2006-03-31 2006-03-31
PCT/FI2007/050179 WO2007113387A1 (en) 2006-03-31 2007-03-30 Method and device for treating or selecting cells

Publications (2)

Publication Number Publication Date
JP2009531047A true JP2009531047A (ja) 2009-09-03
JP2009531047A5 JP2009531047A5 (https=) 2010-05-06

Family

ID=38563152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009502136A Pending JP2009531047A (ja) 2006-03-31 2007-03-30 細胞を処理または選択するための方法と装置

Country Status (5)

Country Link
US (1) US20090298171A1 (https=)
EP (1) EP2001997A4 (https=)
JP (1) JP2009531047A (https=)
CA (1) CA2648144A1 (https=)
WO (1) WO2007113387A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012081470A1 (ja) * 2010-12-13 2012-06-21 株式会社資生堂 細胞凝集塊の形成方法
WO2017150294A1 (ja) * 2016-03-04 2017-09-08 良考 山口 多能性幹細胞様スフェロイドの製造方法および多能性幹細胞様スフェロイド

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095409A0 (fi) * 2009-04-14 2009-04-14 Helsingin Yliopisto Soluviljelysupplementti

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139951A (en) * 1990-10-10 1992-08-18 Costar Corporation Culture device having a detachable cell or tissue growth surface
MXPA06008932A (es) * 2004-02-06 2007-01-26 Theradigm Inc Composiciones y metodos que se refieren al cultivo de las celulas madre neurales con celulas estromales de medula osea.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012081470A1 (ja) * 2010-12-13 2012-06-21 株式会社資生堂 細胞凝集塊の形成方法
JP2012187097A (ja) * 2010-12-13 2012-10-04 Shiseido Co Ltd 細胞凝集塊の形成方法
WO2017150294A1 (ja) * 2016-03-04 2017-09-08 良考 山口 多能性幹細胞様スフェロイドの製造方法および多能性幹細胞様スフェロイド

Also Published As

Publication number Publication date
CA2648144A1 (en) 2007-10-11
US20090298171A1 (en) 2009-12-03
EP2001997A4 (en) 2010-05-05
WO2007113387A1 (en) 2007-10-11
EP2001997A1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
JP7344898B2 (ja) 養子注入されたｔ細胞の持続性を増強する方法
Harada et al. Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT
TWI854974B (zh) 表現趨化因子受體及細胞接著分子之cd3陰性細胞之集團、及其用途及其製造方法
CN114958738A (zh) 用于生产TCRγδ+T细胞的方法
Ercolano et al. Immunosuppressive mediators impair proinflammatory innate lymphoid cell function in human malignant melanoma
Berglund et al. Expansion of gammadelta T cells from cord blood: a therapeutical possibility
Franklin et al. Recruited and tissue-resident natural killer cells in the lung during infection and cancer
Maroof et al. Interleukin‐4 can induce interleukin‐4 production in dendritic cells
Humrich et al. Mature monocyte‐derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration
US20170000850A1 (en) Differentiation therapy with cd137 ligand agonists
Lee et al. A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia
Ellegård et al. Complement-opsonized HIV-1 alters cross talk between dendritic cells and natural killer (NK) cells to inhibit NK killing and to upregulate PD-1, CXCR3, and CCR4 on T cells
Zhang et al. EZH2 identifies the precursors of human natural killer cells with trained immunity
JP2009531047A (ja) 細胞を処理または選択するための方法と装置
Kankuri et al. Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells
De Dios et al. CD45 expression on rat acinar cells: involvement in pro-inflammatory cytokine production
Secchiero et al. Differential effects of stromal derived factor‐1α (SDF‐1α) on early and late stages of human megakaryocytic development
Cheng et al. CD 137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells
Jung et al. Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen‐activated protein kinase
JP7529373B2 (ja) 抗ｃｄ２６リガンドの生物活性を決定するための細胞内定量法
Drãcea et al. New thioureides of 2-(4-methylphenoxymethyl) benzoic acid with antimicrobial activity
Franklin Group 1 Innate Lymphoid Cells in Lung Cancer and Infection
Rhee Regulation of T follicular helper cells in the germinal center reaction of chronic graft-versus-host disease
Teramo et al. PF367 MOLECULAR EVIDENCE THAT ATOVAQUONE IS A NEW STAT3‐INHIBITOR COUNTERBALANCING LEUKEMIC CELL PRO‐SURVIVAL IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Kaur Microenvironment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100317

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120510

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130204